Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.

Importance Although children mainly experience mild COVID-19 disease, hospitalization rates are increasing, with limited understanding of underlying factors. There is an established association between race and severe COVID-19 outcomes in adults in England; however, whether a similar association exists in children is unclear. Objective To investigate the association between race and childhood COVID-19 testing and hospital outcomes. Design, Setting, Participants In this cohort study, children (0-18 years of age) from participating family practices in England were identified in the QResearch database between January 24 and November 30, 2020. The QResearch database has individually linked patients with national SARS-CoV-2 testing, hospital admission, and mortality data. Exposures The main characteristic of interest is self-reported race. Other exposures were age, sex, deprivation level, geographic region, household size, and comorbidities (asthma; diabetes; and cardiac, neurologic, and hematologic conditions). Main Outcomes and Measures The primary outcome was hospital admission with confirmed COVID-19. Secondary outcomes were SARS-CoV-2-positive test result and any hospital attendance with confirmed COVID-19 and intensive care admission. Results Of 2 576 353 children (mean [SD] age, 9.23 [5.24] years; 48.8% female), 410 726 (15.9%) were tested for SARS-CoV-2 and 26 322 (6.4%) tested positive. A total of 1853 children (0.07%) with confirmed COVID-19 attended hospital, 343 (0.01%) were admitted to the hospital, and 73 (0.002%) required intensive care. Testing varied across race. White children had the highest proportion of SARS-CoV-2 tests (223 701/1 311 041 [17.1%]), whereas Asian children (33 213/243 545 [13.6%]), Black children (7727/93 620 [8.3%]), and children of mixed or other races (18 971/147 529 [12.9%]) had lower proportions. Compared with White children, Asian children were more likely to have COVID-19 hospital admissions (adjusted odds ratio [OR], 1.62; 95% CI, 1.12-2.36), whereas Black children (adjusted OR, 1.44; 95% CI, 0.90-2.31) and children of mixed or other races (adjusted OR, 1.40; 95% CI, 0.93-2.10) had comparable hospital admissions. Asian children were more likely to be admitted to intensive care (adjusted OR, 2.11; 95% CI, 1.07-4.14), and Black children (adjusted OR, 2.31; 95% CI, 1.08-4.94) and children of mixed or other races (adjusted OR, 2.14; 95% CI, 1.25-3.65) had longer hospital admissions (≥36 hours). Conclusions and Relevance In this large population-based study exploring the association between race and childhood COVID-19 testing and hospital outcomes, several race-specific disparities were observed in severe COVID-19 outcomes. However, ascertainment bias and residual confounding in this cohort study should be considered before drawing any further conclusions. Overall, findings of this study have important public health implications internationally.

[1]  K. Bhaskaran,et al.  Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform , 2021, The Lancet.

[2]  J. Ludvigsson,et al.  Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden , 2021, The New England journal of medicine.

[3]  N. Halasa,et al.  Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States , 2020, Current opinion in pediatrics.

[4]  K. Reilly,et al.  Race/Ethnicity Among Children With COVID-19–Associated Multisystem Inflammatory Syndrome , 2020, JAMA network open.

[5]  J. Hippisley-Cox,et al.  Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases , 2020, BMJ.

[6]  R. Keogh,et al.  COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults , 2020, Annals of Internal Medicine.

[7]  A. Sheikh,et al.  Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study , 2020, BMJ.

[8]  K. Khunti,et al.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis , 2020, EClinicalMedicine.

[9]  S. Crawford,et al.  Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults , 2020, Annals of Internal Medicine.

[10]  Kathleen M. Akgün,et al.  Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study , 2020, PLoS medicine.

[11]  Sohan Seth,et al.  Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.

[12]  S. McLafferty,et al.  Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  K. Khunti,et al.  The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis , 2020, Endocrinology, diabetes & metabolism.

[14]  K. Reilly,et al.  COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[15]  I. Pavord,et al.  Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people , 2020, Heart.

[16]  R. Bronicki,et al.  Pediatric Intensive Care Unit Admissions for COVID-19: Insights Using State-Level Data , 2020, medRxiv.

[17]  Y. Rozenfeld,et al.  A model of disparities: risk factors associated with COVID-19 infection , 2020, International Journal for Equity in Health.

[18]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[19]  J. Hippisley-Cox,et al.  Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998–2017: A population-based cohort study , 2020, PLoS medicine.

[20]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[21]  Catherine Dodds,et al.  Covid-19: ensuring equality of access to testing for ethnic minorities , 2020, BMJ.

[22]  A. Deep,et al.  Ethnicity and COVID-19 in children with comorbidities , 2020, The Lancet Child & Adolescent Health.

[23]  C. Beyrer,et al.  Assessing differential impacts of COVID-19 on black communities , 2020, Annals of Epidemiology.

[24]  M. Lenge,et al.  Children with Covid-19 in Pediatric Emergency Departments in Italy , 2020, The New England journal of medicine.

[25]  R. Badolato,et al.  Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[27]  Olaf Klungel,et al.  The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) , 2018, British Medical Journal.

[28]  M. Heys,et al.  Length of paediatric inpatient stay, socio-economic status and hospital configuration: a retrospective cohort study , 2017, BMC Health Services Research.

[29]  S. Crowe,et al.  Ethnic and socioeconomic variation in incidence of congenital heart defects , 2016, Archives of Disease in Childhood.

[30]  J. Wardle,et al.  Barriers to cervical cancer screening among ethnic minority women: a qualitative study , 2015, Journal of Family Planning and Reproductive Health Care.

[31]  Rick Lukanz,et al.  Health and Social Care , 2018, Public Service Accountability.

[32]  T. Noori,et al.  HIV testing and counselling for migrant populations living in high-income countries: a systematic review , 2012, European journal of public health.

[33]  Carol Coupland,et al.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database , 2010, BMJ : British Medical Journal.

[34]  S. Pocock,et al.  Guideline The Strengthening the Reporting of Observational Studies in Epidemiology ( STROBE ) Statement : Guidelines for reporting observational studies * , 2014 .

[35]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[36]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[37]  M. Banerjee,et al.  Diabetes and ethnic minorities , 2005, Postgraduate Medical Journal.

[38]  Brian Hurwitz,et al.  Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis , 2005, The Lancet.

[39]  Benjamin Schwartz,et al.  Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. , 2004, Pediatrics.

[40]  M. Hickman,et al.  Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic‐specific rates , 1999, British journal of haematology.

[41]  M. Levene,et al.  Prevalence and type of cerebral palsy in a British ethnic community: the role of consanguinity , 1997, Developmental medicine and child neurology.

[42]  Eugene Vayda,et al.  Inequalities in Health: The Black Report , 1988 .

[43]  F. Jung,et al.  Products , 1968, ADHESION ADHESIVES&SEALANTS.

[44]  R. Evans European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).